中新社北京1月11日电 (记者 欧阳开宇)中国2012年实施基本药物全覆盖抽验，合格率为98.7%。

Beijing on January 11, China news service (Reporter OuYangKaiYu)In 2012 China implement basic drug full cover sample,Percent of pass is 98.7%.

　　全国食品药品监督管理暨党风廉政建设工作会议10-11日在北京举行。国家食品药品监督管理局局长尹力在会上透露上述信息。

The national food and drug supervision and administration and the party construction of a clean and honest administration work conference 10 to 11, held in Beijing.State food and drug administration YinLi said at the meeting of the above information.

　　尹力说，中国严格基本药物质量监管，2012年各地增补基本药物品种逐步纳入电子监管范围，全年完成基本药物抽验9.6万批次。

YinLi said,China's strict basic drug quality supervision,Around 2012 supplement essential drugs variety gradually into the electronic supervision range,The complete basic drug collected 96000 batches.

　　基本药物是指能够满足基本医疗卫生需求，剂型适宜、保证供应、基层能够配备、国民能够公平获得的药品，主要特征是安全、必需、有效、价廉。中国基本药物制度已初步建立。

Essential drugs is to point to to meet the basic medical needs,Dosage form suitable for/To guarantee the supply/Base can be equipped with/National to be fair for drugs,The main character is safe/must/effective/price.China has initially established a system of basic drugs.

　　在过去的一年，中国还建立起基本药物重点品种不良反应动态监测分析制度。尹力说，中国基本药物安全风险预警能力进一步提高，全年没有重大质量安全事件。

In the past year,China has set up basic drug key varieties adverse reaction dynamic monitoring and analysis system.YinLi said,China's basic drug safety risk early warning capability to further improve,The quality and safety of no major events.

　　尹力表示，未来在药品标准提高、仿制药一致性评价、新修订《药品生产质量管理规范》和《药品经营质量管理规范》实施、监督抽验、不良反应监测、电子监管等工作中，要优先考虑基本药物。

YinLi said,In the future to improve drug standards/Generics consistency evaluation/The new revised[The quality control standard for pharmaceutical production]and[The quality control standard for pharmaceutical business]implementation/Market surveillance and/Adverse reaction monitoring/Electronic supervision work,To preferred essential drugs.

　　“力争在2013年启动《药品管理法》修订和《执业药师法》的制订，开展50个品种的仿制药质量一致性评价，启动1500个药品标准提高项目。”尹力说。

"Strive to begin in 2013[Drug administration law]Revision and[Licensed pharmacists method]The formulation of,Carry out fifty kinds of generics quality consistency evaluation,Start 1500 drug standards improve project."YinLi said.

　　在尹力所做的报告中，中国官方还将强化药物临床试验项目监管和机构日常监管，严格基本药物以及高风险产品、中药材、中药饮片、药用辅料等监管。(完)

In YinLi report,China's official will also strengthen the drug clinical trial institution project supervision and daily supervision,Strict basic drugs and high-risk products/Chinese herbal medicine/Chinese medicine yinpian/Pharmaceutical raw materials and supervision.(finish)